bluebird bio Market Cap

Evogene has a market cap or net worth of 35.40 million as of August 5, 2025. Its market cap has decreased by -70.30% in one year.

Market Cap

35.40M

Enterprise Value

68.10M

Revenue

25.19M

Ranking

n/a

PE Ratio

n/a

Stock Price

$409.70

Market Cap Chart

Since October 15, 2007, Evogene's market cap has decreased from 113.15M to 35.40M, a decrease of -68.72%. That is a compound annual growth rate of -6.31%.

Market Cap History

Date	Market Cap	% Change
Aug 5, 2025	35.40M	-25.25%
Dec 31, 2024	47.35M	-68.75%
Dec 31, 2023	151.55M	64.52%
Dec 29, 2022	92.12M	-58.37%
Dec 30, 2021	221.26M	-59.72%
Dec 31, 2020	549.28M	305.78%
Dec 31, 2019	Upgrade Pro	Upgrade Pro
Dec 31, 2018	Upgrade Pro	Upgrade Pro
Dec 31, 2017	Upgrade Pro	Upgrade Pro
Dec 29, 2016	Upgrade Pro	Upgrade Pro
Dec 31, 2015	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Teva Pharmaceutical Industries	60.25B
Danel (Adir Yeoshua)	2.76B
Kamada	1.46B
Bait Bakfar	1.12B
SofWave Medical	884.68M
BrainsWay	757.07M
Novolog (Pharm-Up 1966)	710.12M
Ilex Medical	675.20M

Market Cap Rankings